Skip to main content
OpenTrials
Completed

NCT Number: NCT00666523

Effect of Phytalgic in Osteoarthritis (OA)

The objective of the study is to test the effects of a herbal supplement, Phytalgic, on the symptoms of osteoarthritis of the knee or hip, in patients with OA using NSAIDs or analgesics on a regular basis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dept of Pharmacology, U-Bordeaux2, BP36

Bordeaux, 33076, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • knee or hip osteoarthritis
  • regular NSAIDs/analgesic treatment
  • signed inform consent

Exclusion criteria

  • incapacity to understand study
  • irregular NSAID treatment

Treatment and study plan

Phytalgic

Dietary Supplement

3/day

Placebo

Dietary Supplement

3/Day

Primary outcomes

  1. use of NSAIDs or analgesics

    Time frame: 3 months

Secondary outcomes

  1. WOMAC function scale

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Université Victor Segalen Bordeaux 2

Other

Collaborators

  • laboratoire Phythea, France

Registry information

Official study title

Randomized Double-Blind Study of Food Supplement Phytalgic on Symptoms of Osteoarthritis

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Apr 25, 2008
Registry last updated
Apr 25, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.